InvaGen Pharmaceuticals, Inc.

InvaGen Pharmaceuticals Inc. plans to cut a total of 205 jobs across two Long Island factories as disclosed in WARN filings and company statements. The company will lay off 160 of 408 employees at its Central Islip factory (550 South Research Place) and 45 of 96 employees at its Hauppauge facility (600 Old Willets Path); terminations are scheduled to be completed by Dec. 20 according to the notices. InvaGen’s HR vice president confirmed the planned layoffs and said affected workers were notified in August, while parent Cipla Ltd. said the cuts are a strategic realignment toward more complex and specialized products and that the two sites will remain open. The article places the reductions in the context of Long Island’s generally expanding pharmaceutical sector and notes the layoffs won’t trigger repayment of prior tax breaks tied to the Central Islip plant.